Nondisclosure of HIV status in a clinical trial setting: Antiretroviral drug screening can help distinguish between newly diagnosed and previously diagnosed HIV infection

Clinical Infectious Diseases

Volumn 58, Issue 1, 2014, Pages 117-120

  Marzinke, Mark A ^a   Clarke, William ^a   Wang, Lei ^b   Cummings, Vanessa ^a   Liu, Ting Yuan ^b   Piwowar Manning, Estelle ^a   Breaud, Autumn ^a   Griffith, Sam ^c   Buchbinder, Susan ^d   Shoptaw, Steven ^e   Del Rio, Carlos ^f   Magnus, Manya ^g   Mannheimer, Sharon ^h   Fields, Sheldon D ⁱ   Mayer, Kenneth H ^j   Wheeler, Darrell P ^k   Koblin, Beryl A ^l   Eshleman, Susan H ^a   Fogel, Jessica M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c FAMILY HEALTH INTERNATIONAL   (United States)

^d SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f EMORY UNIVERSITY   (United States)

^g GEORGE WASHINGTON UNIVERSITY   (United States)

^h Och Spine at New York Presbyterian Hospitals   (United States)

ⁱ FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^j HARVARD MEDICAL SCHOOL   (United States)

^k LOYOLA UNIVERSITY CHICAGO   (United States)

^l NEW YORK BLOOD CENTER   (United States)

more..

Author keywords

antiretroviral; HIV; MSM; new diagnosis; self report

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ARTICLE; DRUG SCREENING; FISHER EXACT TEST; FOLLOW UP; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEN WHO HAVE SEX WITH MEN; PRIORITY JOURNAL; SELF REPORT; UNITED STATES; VIRUS LOAD;

ANTIRETROVIRAL; HIV; MSM; NEW DIAGNOSIS; SELF-REPORT;

ADULT; ANTI-RETROVIRAL AGENTS; HIV; HIV INFECTIONS; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED;

EID: 84891354327     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit672     Document Type: Article

References (11)

1. McNairy ML, Cohen M, El-Sadr WM. Antiretroviral therapy for prevention is a combination strategy. Curr HIV/AIDS Rep 2013; 10:152-8.
2. Sullivan AK, Savage EJ, Lowndes CM, et al. Non-disclosure of HIV status in UK sexual health clinics-a pilot study to identify non-disclosure within a national unlinked anonymous seroprevalence survey. Sex Transm Infect 2013; 89:120-1.
3. Fogel JM, Wang L, Parsons TL, et al. Undisclosed antiretroviral drug use in a multi-national clinical trial (HPTN 052) [epub ahead of print]. J Infect Dis 2013.
4. Kahle EM, Kashuba A, Baeten JM, et al. Unreported antiretroviral use by HIV-1 infected participants enrolling in a prospective research study. J Acquir Immune Defic Syndr. In press.
5. Minnis AM, Gandham S, Richardson BA, et al. Adherence and acceptability in MTN 001: a randomized cross-over trial of daily oral and topical tenofovir for HIV prevention in women. AIDS Behav 2013; 17:737-47.
6. Marzinke MA, Breaud A, Clarke W. Development of a high resolution accurate mass method for the multiplexed monitoring of antiretroviral agents in human serum. In: 47th Meeting of the Academy of Clinical Laboratory Physicians and Scientists, Milwaukee, WI, 31 May-2 June, 2012.
7. Koblin BA, Mayer KH, Eshleman SH, et al. Correlates of HIV acquisition in a cohort of black men who have sex with men in the United States: HIV Prevention Trials Network (HPTN) 061. PLoS One 2013; 8:e70413.
8. Weber J, Tatoud R, Fidler S. Postexposure prophylaxis, preexposure prophylaxis or universal test and treat: the strategic use of antiretroviral drugs to prevent HIV acquisition and transmission. AIDS 2010; 24 (suppl 4):S27-39.
9. Zablotska IB, Prestage G, deWit J, Grulich AE, Mao L, Holt M. The informal use of antiretrovirals for preexposure prophylaxis of HIV infection among gay men in Australia. J Acquir Immune Defic Syndr 2013; 62:334-8.
10. Grelotti DJ, Closson EF, Mimiaga MJ. Pretreatment antiretroviral exposure from recreational use. Lancet Infect Dis 2013; 13:10-12.
11. Laeyendecker O, Piwowar-Manning E, Fiamma A, et al. Estimation of HIV incidence in a large, community-based, randomized clinical trial: NIMH Project Accept (HIV Prevention Trials Network 043). PLoS One 2013; 8:e68349.